Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Fischman

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Cancer Treatment and Research|July 16, 2008
PET imaging of brain tumorsAlan J Fischman
Radiologic Clinics of North America|February 8, 2005
Role of [18F]-dopa-PET imaging in assessing movement disordersAlan J Fischman
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Evaluation of Rare Tumors with [F-18]Fluorodeoxyglucose Positron Emission TomographyHossein Jadvar, Alan J. Fischman
Radiologic Clinics of North America|March 11, 2008
Nuclear imaging in the genitourinary tract: recent advances and future directionsWei He, Alan J Fischman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2003
Who should read and interpret 18F-FDG PET studies?Alan J Fischman, James H Thrall
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Pancreatic imaging with 11C-dihydrotetrabenazine PET: a perspectiveShawn P Fagan, Alan J Fischman
Biological Psychiatry|June 14, 2005
The neurobiology of attention-deficit/hyperactivity disorderAlan J Fischman, Bertha K Madras
Menopause (New York, N.Y.)|November 2, 2006
Cortical activations, psychiatric symptoms, and climacteric womenAlan J Fischman, Rajendra D Badgaiyan
Chest|September 15, 2004
Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?Suzanne L Aquino, Alan J Fischman
Behavioural Brain Research|February 28, 2002
The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD)Bertha K Madras, Gregory M Miller, Alan J Fischman
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Cancer Treatment and Research|July 16, 2008
PET imaging of brain tumorsAlan J Fischman
Radiologic Clinics of North America|February 8, 2005
Role of [18F]-dopa-PET imaging in assessing movement disordersAlan J Fischman
Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T|October 1, 2003
Evaluation of Rare Tumors with [F-18]Fluorodeoxyglucose Positron Emission TomographyHossein Jadvar, Alan J. Fischman
Radiologic Clinics of North America|March 11, 2008
Nuclear imaging in the genitourinary tract: recent advances and future directionsWei He, Alan J Fischman
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2003
Who should read and interpret 18F-FDG PET studies?Alan J Fischman, James H Thrall
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2009
Pancreatic imaging with 11C-dihydrotetrabenazine PET: a perspectiveShawn P Fagan, Alan J Fischman
Biological Psychiatry|June 14, 2005
The neurobiology of attention-deficit/hyperactivity disorderAlan J Fischman, Bertha K Madras
Menopause (New York, N.Y.)|November 2, 2006
Cortical activations, psychiatric symptoms, and climacteric womenAlan J Fischman, Rajendra D Badgaiyan
Chest|September 15, 2004
Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?Suzanne L Aquino, Alan J Fischman
Behavioural Brain Research|February 28, 2002
The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD)Bertha K Madras, Gregory M Miller, Alan J Fischman
Pageof 16